MoneyWorks4Me

Zydus Lifesciences informs about investor presentation

19 May 2026 Evaluate
Pursuant to the provisions of regulation 30 read with regulation 46 of the Listing Regulations, Zydus Lifesciences has informed that it enclosed the Investor Presentation on the audited financial results for the quarter / year ended on March 31, 2026.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.00
Dr. Reddys Labs. 1231.85
Cipla 1325.00
Lupin 1955.80
Zydus Lifesciences 1124.30
View more..